Lupus anticoagulant as a marker of autoimmunity in recurrent pregnancy loss; a case report

Eur J Obstet Gynecol Reprod Biol. 1991 Oct 8;41(3):237-41. doi: 10.1016/0028-2243(91)90030-o.

Abstract

We present a patient with primary antiphospholipid syndrome, as defined by nine pregnancy losses, the presence of lupus anticoagulant (LAC), and the absence of clinical signs and symptoms of autoimmunity. A successful pregnancy was achieved by treatment with low-dose prednisone (15 mg daily) and aspirin (100 mg daily). The patient was followed-up throughout her two last pregnancies and a 6 months postpartum period. Our data indicate that LAC serves as a marker of disease in women with previous pregnancy wastages, and that aspirin-prednisone therapy is beneficial in carefully selected patients.

Publication types

  • Case Reports
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Abortion, Habitual / etiology*
  • Adult
  • Autoimmunity*
  • Biomarkers*
  • Cardiolipins / immunology
  • Female
  • Humans
  • Lupus Coagulation Inhibitor / analysis*
  • Pregnancy

Substances

  • Biomarkers
  • Cardiolipins
  • Lupus Coagulation Inhibitor